Unknown PHASE1 INTERVENTIONAL 1-arm NCT01828918

Biomarkers for the Early Diagnosis, Prediction, Prognosis for Colorectal Cancers

Kaohsiung Medical University Hospital

Sponsor: Academia Sinica, Taiwan

Interventions microRNAs

Updated 7 times since 2017 Last updated: Apr 10, 2013 Started: Jun 30, 2012 Primary completion: Dec 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Colorectal Cancers, this trial is ongoing. The trial is conducted by Academia Sinica, Taiwan and has accumulated 7 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE1
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE1
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE1

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Academia Sinica, Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital

Data source: Kaohsiung Medical University Chung-Ho Memorial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kaohsiung City, Taiwan